Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-011665
Filing Date
2024-10-17
Accepted
2024-10-17 10:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27577
2 filename2.txt TEXT-EXTRACT 981
  Complete submission text file 0000000000-24-011665.txt   39920
Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Filed for) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-39263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)